Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era

Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era

Kehinde Osinowo,1 Fintirimam Sambo-Donga,1 Oluwaseun Ojomo,1 Segun Emmanuel Ibitoye,1 Philip Oluwayemi,1 Morounfola Okunfulure,1 Oladapo Alabi Ladipo,1 Michael Ekholuenetale1,2 1Association for Reproductive and Family Health, Trade and Convention Center, Abuja, Nigeria; 2Department of Epidemiology a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Osinowo K, Sambo-Donga F, Ojomo O, Ibitoye SE, Oluwayemi P, Okunfulure M, Ladipo OA, Ekholuenetale M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
family planning
contraceptive
nigeria
dmpa-sc
self-injection
birth control
Gynecology and obstetrics
RG1-991
Acceso en línea:https://doaj.org/article/1af77b02412d47b48f69274f5984dfb0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/1af77b02412d47b48f69274f5984dfb0

Ejemplares similares